Replies to post #22513 on Ocata Therapeutics Inc fka OCAT

[rocky301]

louisa,

thanks for the article. This part is key, imo.

"The eventual goal of developing the cells as a treatment for Stargardt's is not just treating the syndrome, says ACT's William Caldwell, but developing similar treatments for blindness-related ailments such as macular degeneration, which afflicts increasing numbers of aging Baby Boomers."